Medicine & Life Sciences
Leishmania donovani
100%
Antimony Sodium Gluconate
99%
Visceral Leishmaniasis
75%
Parasites
55%
Surface-Active Agents
47%
Leishmaniasis
45%
Pharmaceutical Preparations
27%
Infections
26%
Paromomycin
26%
Antimony
24%
Amphotericin B
23%
Glutamate-Cysteine Ligase
19%
Liver
19%
Spleen
18%
Vaccines
18%
Leishmania
17%
miltefosine
16%
Antiparasitic Agents
15%
gamma-glutamylcysteine
15%
Interleukin-4
15%
Macrophages
15%
Bone Marrow
14%
Antigens
12%
Leishmania mexicana
11%
Interleukin-13
11%
Therapeutics
11%
Inhibitory Concentration 50
11%
Cutaneous Leishmaniasis
10%
Drug Compounding
9%
Vaccination
9%
Propolis
9%
Biological Products
9%
In Vitro Techniques
8%
Immunity
8%
Animals
8%
Structure-Activity Relationship
8%
Influenza Vaccines
7%
Lipids
7%
Metabolomics
7%
Neutrophils
7%
DNA
7%
Libya
7%
Leishmania major
7%
Larva
6%
Nanoparticles
6%
Tuberculosis
6%
Tetanus Toxoid
6%
Granuloma
6%
Lung Neoplasms
6%
Chemical Compounds
Sodium Stibogluconate
48%
Niosome
30%
Drug
29%
Amphotericin B
19%
Binding Agent
12%
Nonionic Surfactant
11%
Dose
10%
Peroral
10%
Miltefosine
7%
Antigen
6%
Paromomycin
5%
Antimycobacterial Agent
5%
Antileishmanial Agent
5%
Gemcitabine
5%
Agriculture & Biology
Leishmania donovani
26%
infection
13%
niosomes
12%
vaccines
11%
parasites
10%
glutamate-cysteine ligase
9%
cutaneous leishmaniasis
8%
cysteine synthase
8%
antigens
8%
immune response
8%
vaccination
8%
mice
7%
antimony
6%
mouth
6%
Leishmania major
6%
Strongyloides venezuelensis
6%
Leishmania mexicana
6%
influenza
5%
therapeutics
5%
antibodies
5%
methyl chloride
5%
sodium
5%
influenza vaccines
5%